Although clinical studies of NSAIDs in periodontitis patients indicate that COX-2 inhibition may have protective effects on bone damage (40), experimental evidence directly showing the functional role of the COX-2-PGE2 axis in bone resorption in humans is lacking. This evidence concerns the gene PTGS2 and periodontitis.